Gritstone Bio is a company headquartered in the United States.
Gritstone Bio develops immunotherapies that use multi-specific antibodies to target tumor cells and stimulate durable immune responses, focusing on cancers such as lung, gastric, esophageal, head & neck, and cervical cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.